UNITY Biotechnology to Participate in the Cowen 43rd Annual Health Care Conference

Rhea-AI Summary

SOUTH SAN FRANCISCO, Calif., Feb. 28, 2023 – UNITY Biotechnology, a biotechnology firm focused on therapeutics to address aging-related diseases, announced its participation in the Cowen 43rd Annual Health Care Conference. The event is scheduled for March 7, 2023, at 9:50 AM ET, featuring updates from the Company’s Management and one-on-one investor meetings. The presentation will be accessible via webcast and also through the ‘Investors and Media’ section on their website. UNITY's mission includes developing treatments to eliminate or modulate senescent cells, specifically targeting age-related ophthalmologic and neurologic diseases.

SOUTH SAN FRANCISCO, Calif., Feb. 28, 2023 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt, or reverse diseases of aging, today announced that the Company’s Management will provide a corporate update and participate in one-on-one investor meetings at the Cowen 43^rd Annual Health Care Conference on Tuesday, March 7, 2023 at 9:50 AM ET.

The webcast of the presentation will be accessible here and through the “Investors and Media” section of our website, www.unitybiotechnology.com, under “Events & Presentations.”

About UNITY
UNITY is developing a new class of therapeutics to slow, halt or reverse diseases of aging. UNITY’s current focus is on creating medicines to selectively eliminate or modulate senescent cells and thereby provide transformative benefit in age-related ophthalmologic and neurologic diseases. More information is available at www.unitybiotechnology.com or follow us on Twitter and LinkedIn.

Media Contact
Evoke Canale
Katherine Smith
Katherine.smith@evokegroup.com

Investor Contact
LifeSci Advisors, LLC
Joyce Allaire
jallaire@lifesciadvisors.com

Source: Unity Biotechnology, Inc

FAQ

When will UNITY Biotechnology present at the Cowen 43rd Annual Health Care Conference?

UNITY Biotechnology will present on March 7, 2023, at 9:50 AM ET.

Where can I watch the UNITY Biotechnology presentation?

The presentation can be viewed via webcast on the UNITY Biotechnology website in the 'Investors and Media' section.

What is the focus of UNITY Biotechnology's therapeutics?

UNITY Biotechnology focuses on developing therapies to slow, halt, or reverse diseases associated with aging.

What are senescent cells and why does UNITY Biotechnology target them?

Senescent cells are damaged cells that contribute to aging and age-related diseases; UNITY targets them to improve health outcomes.

What specific diseases is UNITY Biotechnology targeting?

UNITY Biotechnology is currently focusing on age-related ophthalmologic and neurologic diseases.